채용
Celestial AI

Celestial AI
AI accelerator chips
Machine Learning
Hardware Acceleration
Distributed Systems
Photonic Computing
채용 중인 포지션
0개 포지션
현재 채용 중인 포지션이 없습니다
제품 및 서비스
PH
Photonic Fabric
Hardware Platform
OR
Orion Photonic Accelerator
AI Accelerator
PH
Photonic Memory Interface
Memory Technology
OP
Optical I/O Technology
Interconnect Technology
AI
AI Development Platform
Software Platform
CU
Custom Silicon Solutions
Custom Hardware
유사 기업

Eve
growth
AI tools for law firms
Hillsborough, North Carolina
1,001-5,000
Valuation 1.0B

Andromeda
growth
AI compute
Valuation 1.5B

Unconventional AI
growth
AI computing infrastructure
1-50
Valuation 4.5B

Z.ai
late
Artificial Intelligence
Beijing, China
1,001-5,000
Valuation 32.8B
Cambricon
late
AI chip designer
北京市, 中国
1,001-5,000
Valuation 72.5B

Legora
growth
AI legal assistant
Valuation 5.6B
뉴스 & 버즈
All
X
News
HN
YouTube
Open-source isolated runtime for AI agents
HN
·
3일 전
·
2
·
3
Stifel Raises Marvell’s Target to $140: Is This AI Chip Dark Horse Ready to Break Out? - 24/7 Wall St.
24/7 Wall St.
News
·
5일 전
Show HN: SmolVM – open-source sandbox for coding and computer-use agents
SmolVM is an open-source local sandbox for AI agents on macOS and Linux.<p>I started building it because agent workflows need more than isolated code execution. They need a reusable environment: write files in one step, come back later, snapshot state, pause/resume, and increasingly interact with browsers or full desktop environments.<p>Right now SmolVM is a Python SDK and CLI focused on local developer experience.<p>Current features include: - local sandbox environments - macOS and Linux s
HN
·
1주 전
·
8
·
3
Firms act on Marvell Technology’s USD3.25bn Celestial AI buy - Law.asia
Law.asia
google-news
·
3주 전
My portfolio and short thesis for each stock
Please let me know what you think of this portfolio any critique or advice would be helpful TSM 15% - (Avg entry - 292$) The only manufacturer of the world's most advanced chips. Every AI accelerator on the planet runs through TSMC's fabs and no competitor is within a decade of catching up. LLY 12% - (Avg entry - $850) Owns the defining drug franchise of this generation with tirzepatide and orforglipron targeting obesity and diabetes at scale. Yes, overpriced but price falling to low 900 makes
·
1개월 전
·
35
·
29
더 보기 (15개 남음)
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
연봉 정보
6개 데이터
Senior/L5
Senior/L5
1개 리포트
$240,531
총 연봉
기본급
$185,024
주식
-
$240,531
$240,531
연락처 및 위치